Satsuma Pharmaceuticals, Inc. - stock earnings
Stock symbol STSA is outdated, potentially delisted? Maybe it is available on other exchange?
STSA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -23.1 million USD | ? USD |
| 2022Q3 | -15.1 million USD | ? USD |
| 2022Q2 | -16.3 million USD | ? USD |
| 2022Q1 | -15.5 million USD | ? USD |
| 2021Q4 | -15.6 million USD | ? USD |
| 2021Q3 | -13.3 million USD | ? USD |
| 2021Q2 | -11.8 million USD | ? USD |
| 2021Q1 | -10.5 million USD | ? USD |
| 2020Q4 | -12.5 million USD | ? USD |
| 2020Q3 | -12.0 million USD | ? USD |
STSA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -51.2 million USD | ? USD |
| 2020 | -47.6 million USD | ? USD |
| 2019 | -28.2 million USD | ? USD |
| 2018 | -7.3 million USD | ? USD |
| 2017 | -5.2 million USD | ? USD |
STSA
Price: $1.10
52 week price:
Dividend Yield: 0.72%
Payout Ratio Range:
Earnings Per Share: -0.85 USD
P/E Ratio: -1.58
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 58951
Market Capitalization: 34.8 million
Average Dividend Frequency: 3